Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Aprea Therapeutics' Safety Review Committee Approves 800 mg Dosing of ATRN-119 in ABOYA-119 Trial

Wednesday, May 29, 2024

Aprea Therapeutics Inc a clinicalstage biopharmaceutical company focused on precision oncology through synthetic lethality announced that the Safety Review Committee

Cytek® Biosciences Gains Approval for 1-Laser and 2-Laser 6-Color TBNK Reagents for Clinical Use in China

Wednesday, May 29, 2024

Cytek Biosciences Inc has announced that its laser and laser color TBNK reagent cocktails have received approval from the China National Medical Products Administration for clinical diagnostic use on the Cytek

FDA Approves Initial Interchangeable Biosimilar for Two Rare Conditions

Wednesday, May 29, 2024

Today the US Food and Drug Administration authorized Bkemv as the inaugural interchangeable biosimilar to Soliris for treating specific rare diseases Bkemv has been endorsed for treating the following indications which are presently also approved for...

Datopotamab Deruxtecan Demonstrates Clinically Significant Increase in Overall Survival Compared to Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer

Tuesday, May 28, 2024

In the TROPIONLung phase trial datopotamab deruxtecan demonstrated promising overall survival trends

FDA Prioritizes Review of Sarclisa for Newly Diagnosed Multiple Myeloma Patients Excluded from Transplant Eligibility

Tuesday, May 28, 2024

The US Food and Drug Administration has given priority review status to the Supplemental Biologics License Application for Sarclisa in combination with bortezomib lenalidomide and dexamethasone

Roche and Hitachi High-Tech Extend Their 46-Year Collaboration, Enabling Further Progress in Diagnostic Testing

Monday, May 27, 2024

Roche and Hitachi HighTech have recently announced a significant extension of their partnership committing to at least another decade of collaboration This renewed commitment strengthens their joint

Dizal Unveils New Biomarker Analysis Data, Showcasing Sunvozertinib's Effectiveness for Treating Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Saturday, May 25, 2024

Dizal a biopharmaceutical company dedicated to developing innovative treatments for cancer

Laekna Gains FDA Approval for Phase III Trial of LAE002 (Afuresertib) and LAE001 in Prostate Cancer Treatment

Friday, May 24, 2024

Laekna Inc a leading biotechnology company has achieved a significant milestone with the approval from the US Food and Drug Administration for the phase III clinical trial protocol of LAE an AKT inhibitor

Providence Collaborates with Ontario Institute for Cancer Research to Explore mRNA Therapeutics

Friday, May 24, 2024

Providence Therapeutic Holdings Inc a company specializing in messenger RNA and lipid nanoparticle platform technology for vaccine and therapeutic development has joined forces with the Ontario

GCCL Enhances Gene/Cell Therapy Clinical Trials through ddPCR Technology

Thursday, May 23, 2024

GCCL a pioneering Korean company specializing in clinical trial sample analysis has introduced a groundbreaking advancement to the industry with the incorporation of Droplet Digital PCR devices This marks a significant leap forward in the analysis of...

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024